Safety and Efficacy of KL003 Cell Injection in Severe Sickle Cell Disease
Clinical trial NCT07436767 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07436767
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2028-09-30
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.